The new partnership aims to serve healthcare providers, researchers within the life sciences, biopharmaceutical and medical device manufacturers, and patients. Cognizant will help organizations build, deploy and operate custom applications on Philips HealthSuite. Cognizant will help healthcare providers leverage the platform to monitor patients outside of traditional settings and give patients a way to learn about their health. They’ll help biopharmaceutical and medical device manufacturers build applications to use advanced analytics to guide clinical development decisions. The IT services company will help life sciences firms use HealthSuite for remote patient monitoring and decentralized clinical trials. “Despite advances, patients and clinicians still face a fragmented technology and data landscape that holds back innovative healthcare services which improve care quality and the human experience,” Shez Partovi, Royal Philips’ chief innovation & strategy officer, said in a statement. “Philips is committed to driving the digital transformation of healthcare. Partnering with Cognizant’s experienced digital engineering teams will accelerate the adoption of solutions built on Philips HealthSuite, delivering digital solutions across the healthcare continuum in a secure and compliant manner and ultimately helping guide better health decisions for patients.” Over the last five years, Philips has turned its focus strictly to healthcare technology and now has three business core business segments in this area: Personal Health, Diagnosis & Treatment and Connected Care. The company brought in €19.5 billion in 2020 and expects to grow around 5% to 6%each year through 2025. By Philips’ own estimate, the overall health technology market is expected to grow around 4% each year.
